文献速递认知障碍与痴呆帕金森病与运动障碍

临床-遗传评分预测帕金森病认知障碍:九队列纵向分析

Prediction of cognition in Parkinson's disease with a clinical-genetic score: a longitudinal analysis of nine cohorts.
PubMed 文献 · Lancet Neurol · 2017-06-16

该纵向分析基于北美和欧洲九个帕金森病队列(1986-2016年)数据,构建并验证了一个临床-遗传评分,用于预测帕金森病患者的全局认知障碍(MMSE≤25)。模型性能在随机重采样中稳定,为帕金森病认知预后提供了潜在工具。

要点

  • 模型包含年龄、基线MMSE、教育年限、运动评分、性别、抑郁和GBA突变状态。

核心结论

  • 临床-遗传评分可预测帕金森病患者未来认知健康或障碍,有助于优化认知干预试验和预后判断。

研究设计与样本

  • 发现队列1350例来自六个队列,复制队列1132例来自三个独立纵向队列。

主要发现

  • 预测模型纳入年龄、基线MMSE、教育年限、运动检查评分、性别、抑郁和β-葡萄糖脑苷脂酶(GBA)突变状态。

关键数值与推荐

  • 全局认知障碍定义为简易精神状态检查(MMSE)≤25。

临床怎么用

  • 该评分可用于帕金森病患者认知预后的早期分层,辅助识别高风险患者。
  • 模型有助于筛选适合认知干预试验的人群,并指导临床预后沟通。

以上解读依据论文摘要(全文未开放获取或许可不允许翻译转载)。

原文

BACKGROUND: Cognitive decline is a debilitating manifestation of disease progression in Parkinson's disease. We aimed to develop a clinical-genetic score to predict global cognitive impairment in patients with the disease. METHODS: In this longitudinal analysis, we built a prediction algorithm for global cognitive impairment (defined as Mini Mental State Examination [MMSE] ≤25) using data from nine cohorts of patients with Parkinson's disease from North America and Europe assessed between 1986 and 2016. Candidate predictors of cognitive decline were selected through a backward eliminated Cox's proportional hazards analysis using the Akaike's information criterion. These were used to compute the multivariable predictor on the basis of data from six cohorts included in a discovery population. Independent replication was attained in patients from a further three independent longitudinal cohorts. The predictive score was rebuilt and retested in 10 000 training and test sets randomly generated from the entire study population. FINDINGS: 3200 patients with Parkinson's disease who were longitudinally assessed with 27 022 study visits between 1986 and 2016 in nine cohorts from North America and Europe were assessed for eligibility. 235 patients with MMSE ≤25 at baseline and 135 whose first study visit occurred more than 12 years from disease onset were excluded. The discovery population comprised 1350 patients (after further exclusion of 334 with missing covariates) from six longitudinal cohorts with 5165 longitudinal visits over 12·8 years (median 2·8, IQR 1·6-4·6). Age at onset, baseline MMSE, years of education, motor exam score, sex, depression, and β-glucocerebrosidase (GBA) mutation status were included in the prediction model. The replication population comprised 1132 patients (further excluding 14 patients with missing covariates) from three longitudinal cohorts with 19 127 follow-up visits over 8·6 years (median 6·5, IQR 4·1-7·2). The cognitive risk score predicted cognitive impairment within 10 years of disease onset with an area under the curve (AUC) of more than 0·85 in both the discovery (95% CI 0·82-0·90) and replication (95% CI 0·78-0·91) populations. Patients scoring in the highest quartile for cognitive risk score had an increased hazard for global cognitive impairment compared with those in the lowest quartile (hazard ratio 18·4 [95% CI 9·4-36·1]). Dementia or disabling cognitive impairment was predicted with an AUC of 0·88 (95% CI 0·79-0·94) and a negative predictive value of 0·92 (95% 0·88-0·95) at the predefined cutoff of 0·196. Performance was stable in 10 000 randomly resampled subsets. INTERPRETATION: Our predictive algorithm provides a potential test for future cognitive health or impairment in patients with Parkinson's disease. This model could improve trials of cognitive interventions and inform on prognosis. FUNDING: National Institutes of Health, US Department of Defense.

来源:Lancet Neurol,查看原文。版权归原作者所有。

引用

  1. Liu G, Locascio JJ, Corvol JC, et al. Prediction of cognition in Parkinson's disease with a clinical-genetic score: a longitudinal analysis of nine cohorts. Lancet Neurol. 2017. PMID: 28629879. doi:10.1016/S1474-4422(17)30122-9

供执业医师工作参考,不替代临床判断;数值与分级以指南原文为准。